Copyright © 2002 by the European Society of Cardiology.
von Willebrand factor and coronary heart disease. Prospective study and meta-analysis
a Department of Public Health Sciences, St George’s Hospital Medical School, London, U.K.
b Department of Public Health and Primary Care, University of Cambridge, U.K.
c Department of Primary Care and Population Sciences, Royal Free and University College London Medical School, U.K.
d Cancer Epidemiology Unit, Radcliffe Infirmary, Oxford, U.K.
e University Department of Medicine, Glasgow Royal Infirmary, Glasgow, U.K.
revised January 2, 2002; accepted February 27, 2002
Abstract
Aims To determine whether circulating von Willebrand factor concentrations are prospectively related to risk of coronary heart disease in the general population.
Methods and Results We measured baseline von Willebrand factor values in the stored serum samples of 625 men with major coronary events and in 1266 controls ‘nested’ in a prospective study of 5661 men aged 40–59 years, recruited from general practices in 18 British towns in 1978–1980 and followed up for 16 years for fatal coronary heart disease and non-fatal myocardial infarction. We conducted a meta-analysis of previous relevant studies to place our results in context. Men in the top third of baseline von Willebrand factor values (tertile cutoff >126IU.dl–1) had an odds ratio for coronary heart disease of 1·83 (95% confidence interval 1·43–2·35; 2P <0·0001) compared with those in the bottom third (tertile cutoff <90IU.dl–1), after adjustments for age and town. The odds ratio was little changed after further adjustment for risk factors (1·82, 95% CI 1·37–2·41), and was not significantly different in an analysis restricted to the 404 cases and 1007 controls without baseline evidence of coronary heart disease (odds ratio 1·53, 95% CI 1·10–2·12). A meta-analysis of all relevant population-based prospective studies (including the present study) yielded a combined odds ratio of 1·5 (95% CI 1·1–2·0). von Willebrand factor values were strongly correlated with Helicobacter pylori seropositivity and circulating concentrations of C-reactive protein (2 P<0·0001 for each), but not with smoking, blood lipids, or most other measured risk factors.
Conclusion Though circulating von Willebrand factor concentrations may be associated with incident coronary heart disease, further studies are needed to determine the extent to which this is causal. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
Key Words: Coronary heart disease, epidemiology, coagulation
f1 Correspondence: Professor Whincup, Department of Public Health Sciences, St George’s Hospital Medical School, London SW17 0RE, U.K.
References
- Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol. 1998;18:1359–1362
[Free Full Text] - Lowe GDO. Haemostatic risk factors for arterial and venous thrombosis. Poller L, Ludlam CA. Recent advances in blood coagulation. Edinburgh: Churchill Livingstone; 1997. p. 69–96
- Fosang AJ, Smith PJ. To clot or not. Nature. 2001;413:475–476[CrossRef][Medline]
- Folsom AR, Wu K, Rosamond WD, Sharret AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1997;96:1102–1108
[Abstract/Free Full Text] - Smith FB, Lee AJ, Fowkes FGR, Rumley A, Lowe GDO. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol. 1997;17:3321–3325
[Abstract/Free Full Text] - Rumley A, Lowe GDO, Sweetnam PM, Yarnell JWG, Ford RP. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol. 1999;105:110–116[CrossRef][Web of Science][Medline]
- Thogersen AM, Jannson J-H, Boman K. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation. 1998;98:2241–2247
[Abstract/Free Full Text] - Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994;88:601–607[Web of Science][Medline]
- Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thomson AG. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ. 1981;283:179–186
[Abstract/Free Full Text] - Walker M, Shaper AG, Lennon L, Whincup PH. Twenty year follow-up of a cohort based in general practice in 24 British towns. J Publ Health Med. 2000;22:479–485
[Abstract/Free Full Text] - Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation. 1994;90:583–612
[Abstract/Free Full Text] - Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle-aged men. Heart. 1996;75:568–572
[Abstract/Free Full Text] - Whincup PH, Danesh J, Walker M. Prospective study of virulent strains of Helicobacter pylori and coronary heart disease in late middle-aged men. Circulation. 2000;101:1647–1652
[Abstract/Free Full Text] - Yarnell JW, Sweetnam PM, Rumley A, Lowe GD. Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study. Arterioscler Thromb Vasc Biol. 2000;20:271–279
[Abstract/Free Full Text] - Wong Y-K, Sueur JM, Fall CHD, Orfila J, Ward ME. The species specificity of the micro-immunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring antibodies against Chlamydia pneumoniae. J Clin Pathol. 1999;2:99–103
- Danesh J, Muir J, Wong Y-K, Ward M, Gallimore R, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins: population-based study. Eur Heart J. 1999;20:954–959
[Abstract/Free Full Text] - Refsum H, Ueland PM, Svardal AM. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem. 1989;35:1921–1927
[Abstract/Free Full Text] - Parving H-H. Concentrations of von Willebrand Factor in diabetes. BMJ. 1996;312:642
[Free Full Text] - Danesh J, Whincup PH, Walker M. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199–204
[Abstract/Free Full Text] - Clarke R, Shipley M, Lewington S. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150:341–353
[Abstract/Free Full Text] - Danesh J, Collins R, Appleby P, Peto R. Fibrinogen, C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease. JAMA. 1998;279:1477–1482
[Abstract/Free Full Text] - Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med. 2000;133:81–91
[Abstract/Free Full Text] - Smith FB, Rumley A, Lee AJ, Leng GC, Fowkes FGR, Lowe GDO. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants. Br J Haematol. 1998;100:758–763[CrossRef][Web of Science][Medline]
- Thompson SG, Kienast J, Pyke SDM, Haverkate F, Van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635–641
[Abstract/Free Full Text] - Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) Study. Arterioscler Thromb Vasc Biol. 2000;20:2019–2023
[Abstract/Free Full Text] - Moss AJ, Goldstein RE, Marder VJ. Thrombogenic factors and recurrent coronary events. Circulation. 1999;99:2517–2522
[Abstract/Free Full Text] - Jansson JH, Nilsson TK, Johnson O. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow-up of survivors of acute myocardial infarction. Heart. 1998;80:334–337
[Abstract/Free Full Text] - Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991;66:351–355
[Abstract/Free Full Text] - Hamsten A, Walldius G, Szamosi A. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3–9[CrossRef][Web of Science][Medline]
- Jager A, van Hinsbergh VWM, Kostense PJ. von Willebrand factor, C-reactive protein and 5-year mortality in diabetic and nondiabetic subjects. Arterioscler Thromb Vasc Biol. 1999;19:3078
- Standl E, Dahl B, Weichenhain B, Stiegler H, Hormann A, Holle R. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia. 1996;39:1540–1545[CrossRef][Web of Science][Medline]
- Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, den Ottolander GJH. Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet. 1992;340:319–323[CrossRef][Web of Science][Medline]
- Blann AD, Miller JP, McCollum CN. von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia. Atherosclerosis. 1997;132:151–156[CrossRef][Web of Science][Medline]
- Blann AD, McCollum CN. von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis. Blood Coagul Fibrinolysis. 1999;10:375–381[Web of Science][Medline]
- Agewall S, Wikstrand J, Fagerberg B. Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men. J Hypertens. 1998;16:537–541[CrossRef][Web of Science][Medline]
- Kalaria VG, Zareba W, Moss AJ. Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patient after acute myocardial infarction. The THROMBO investigators. Am J Cardiol. 2000;85:1401–1408[CrossRef][Web of Science][Medline]
- Pottinger BE, Read RC, Paleolog EM, Pearson JD. von Willebrand factor is an acute phase protein in man. Thromb Res. 1989;53:389–395
- Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol. 1995;90:234–241
- Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430–436[CrossRef][Web of Science][Medline]
- Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk. 1998;5:229–232[Medline]
- Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115–121
[Free Full Text] - Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ. 1999;319:1157–1162
[Abstract/Free Full Text] - McColl K, Murray L, El-Omar E. Symptomatic benefit from eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. N Engl J Med. 1998;339:1869–1874
[Abstract/Free Full Text] - Pernerstorfer T, Eichler H-G, Stohlawetz P, Speiser W, Jilma B. Effects of heparin and aspirin on circulating P-selectin, E-selectin and von Willebrand factor levels in healthy men. Atherosclerosis. 2001;155:389–393[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. de Laat, P. G. de Groot, R. H. W. M. Derksen, R. T. Urbanus, K. Mertens, F. R. Rosendaal, and C. J. M. Doggen Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men Blood, October 22, 2009; 114(17): 3656 - 3661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lowe Factor IX and deep vein thrombosis Haematologica, May 1, 2009; 94(5): 615 - 617. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sattar, G. Wannamethee, N. Sarwar, J. Chernova, D. A. Lawlor, A. Kelly, A. M. Wallace, J. Danesh, and P. H. Whincup Leptin and coronary heart disease: prospective study and systematic review. J. Am. Coll. Cardiol., January 13, 2009; 53(2): 167 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Frankel, J. B. Meigs, J. M. Massaro, P. W.F. Wilson, C. J. O'Donnell, R. B. D'Agostino, and G. H. Tofler Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease: The Framingham Offspring Study Circulation, December 9, 2008; 118(24): 2533 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Welsh, P.H. Whincup, O. Papacosta, S.G. Wannamethee, L. Lennon, A. Thomson, A. Rumley, and G.D.O. Lowe Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men QJM, October 1, 2008; 101(10): 785 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Tabassum, M. Kumari, A. Rumley, G. Lowe, C. Power, and D. P. Strachan Effects of Socioeconomic Position on Inflammatory and Hemostatic Markers: A Life-Course Analysis in the 1958 British Birth Cohort Am. J. Epidemiol., June 1, 2008; 167(11): 1332 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. O. Spiel, J. C. Gilbert, and B. Jilma Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes Circulation, March 18, 2008; 117(11): 1449 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M S O'Neill, A Veves, J A Sarnat, A Zanobetti, D R Gold, P A Economides, E S Horton, and J Schwartz Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility Occup. Environ. Med., June 1, 2007; 64(6): 373 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Rudnicka, C. G. Owen, and D. P. Strachan The Effect of Breastfeeding on Cardiorespiratory Risk Factors in Adult Life Pediatrics, May 1, 2007; 119(5): e1107 - e1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D.O. Lowe, and F. G. R. Fowkes Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke: The Edinburgh Artery Study Circulation, April 24, 2007; 115(16): 2119 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. N. K. Chion, C. J. M. Doggen, J. T. B. Crawley, D. A. Lane, and F. R. Rosendaal ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men Blood, March 1, 2007; 109(5): 1998 - 2000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Rudnicka, A. Rumley, G. D.O. Lowe, and D. P. Strachan Diurnal, Seasonal, and Blood-Processing Patterns in Levels of Circulating Fibrinogen, Fibrin D-Dimer, C-Reactive Protein, Tissue Plasminogen Activator, and von Willebrand Factor in a 45-Year-Old Population Circulation, February 27, 2007; 115(8): 996 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D.O. Lowe, and F. G. R. Fowkes Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study Eur. Heart J., February 1, 2007; 28(3): 354 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Orchard, T. Costacou, A. Kretowski, and R. W. Nesto Type 1 diabetes and coronary artery disease. Diabetes Care, November 1, 2006; 29(11): 2528 - 2538. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Steptoe and M. Marmot Psychosocial, Hemostatic, and Inflammatory Correlates of Delayed Poststress Blood Pressure Recovery Psychosom Med, July 1, 2006; 68(4): 531 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF]
|
|
|
|
 |
|
 E A McIntyre, L Parker, M S Pearce, J Gerrard, N Sattar, A W Craft, and M Walker Relation between birth weight and soluble markers of endothelial function in middle aged subjects. Heart, May 1, 2006; 92(5): 679 - 680. [Full Text] [PDF]
|
|
|
|
|
|
M. Hamer, E. Williams, R. Vuonovirta, P. Giacobazzi, E. L. Gibson, and A. Steptoe The Effects of Effort-Reward Imbalance on Inflammatory and Cardiovascular Responses to Mental Stress Psychosom Med, May 1, 2006; 68(3): 408 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tzoulaki, G. D. Murray, J. F. Price, F. B. Smith, A. J. Lee, A. Rumley, G. D. O. Lowe, and F. G. R. Fowkes Hemostatic Factors, Inflammatory Markers, and Progressive Peripheral Atherosclerosis: The Edinburgh Artery Study Am. J. Epidemiol., February 15, 2006; 163(4): 334 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nuver, A. J. Smit, J. van der Meer, M. P. van den Berg, W. T.A. van der Graaf, M. T. Meinardi, D. Th. Sleijfer, H. J. Hoekstra, A. I. van Gessel, A. M. van Roon, et al. Acute Chemotherapy-Induced Cardiovascular Changes in Patients With Testicular Cancer J. Clin. Oncol., December 20, 2005; 23(36): 9130 - 9137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF]
|
|
|
|
|
|
A. Smith, C. Patterson, J. Yarnell, A. Rumley, Y. Ben-Shlomo, and G. Lowe Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study Circulation, November 15, 2005; 112(20): 3080 - 3087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Woodward, G. D.O. Lowe, D. J. Campbell, S. Colman, A. Rumley, J. Chalmers, B. C. Neal, A. Patel, A. J. Jenkins, B. E. Kemp, et al. Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke Stroke, October 1, 2005; 36(10): 2143 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw Biochemical risk markers: a novel area for better prediction of renal risk? Nephrol. Dial. Transplant., March 1, 2005; 20(3): 497 - 508. [Full Text] [PDF]
|
|
|
|
|
|
J. Yarnell, E. McCrum, A. Rumley, C. Patterson, V. Salomaa, G. Lowe, A. Evans, and on behalf of the MONICA Optional Haemostasis Study Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study{dagger} Eur. Heart J., February 2, 2005; 26(4): 332 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W.G. Leebeek, I. M. van der Meer, and J. C.M. Witteman Genetic Variability of von Willebrand Factor and Atherosclerosis Circulation, August 3, 2004; 110(5): e57 - e57. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Riediker, W. E. Cascio, T. R. Griggs, M. C. Herbst, P. A. Bromberg, L. Neas, R. W. Williams, and R. B. Devlin Particulate Matter Exposure in Cars Is Associated with Cardiovascular Effects in Healthy Young Men Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 934 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Danesh, J. G. Wheeler, G. M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G. D.O. Lowe, M. B. Pepys, and V. Gudnason C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease N. Engl. J. Med., April 1, 2004; 350(14): 1387 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.E. Morange, C. Simon, M.C. Alessi, G. Luc, D. Arveiler, J. Ferrieres, P. Amouyel, A. Evans, P. Ducimetiere, I. Juhan-Vague, et al. Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study Circulation, March 23, 2004; 109(11): 1343 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.D.O. Lowe, J. Danesh, S. Lewington, M. Walker, L. Lennon, A. Thomson, A. Rumley, and P.H. Whincup Tissue plasminogen activator antigen and coronary heart disease: Prospective study and meta-analysis Eur. Heart J., February 1, 2004; 25(3): 252 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Koenig Is measuring endothelial function a good idea for prediction of coronary heart disease complications? Eur. Heart J., November 2, 2002; 23(22): 1728 - 1730. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||